Jazz Pharmaceuticals, Inc. (JAZZ) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $236.04 +0.16%
Revenue Growth %: +7.1%
Financial Fact:
Research and development: 47.8M
Today's EPS Names:
VFS, PKE, More
Revenue Growth %: +7.1%
Financial Fact:
Research and development: 47.8M
Today's EPS Names:
VFS, PKE, More
Join SI Premium – FREE
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) reported Q1 EPS of $0.91, $0.07 better than the analyst estimate of $0.84.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
For earnings history and earnings-related data on Jazz Pharmaceuticals, Inc. (JAZZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX (SPCX) PT Raised to $230 at Goldman Sachs ahead of earnings release
- Proficient Auto Logistics Sets Date to Report Third Quarter 2026 Financial Results; Announces Participation in Stephens Annual Investment Conference
- Goldman Sachs names top utility stocks ahead of earnings season
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
